URBN
66
2
LNC
45
-4
BAX
27
-2
KSS
42
-3
FLR
48
3
UA
57
4
LEG
31
3
BA
45
-3
CMG
69
-3
EXR
59
4
DOW
30
2
IFF
53
2
LRCX
46
-2
EQR
60
6
T
48
3
PNR
74
5
PX
73
-6
SYY
47
-2
EQT
57
-3
CAH
60
2
URBN
66
2
LNC
45
-4
BAX
27
-2
KSS
42
-3
FLR
48
3
UA
57
4
LEG
31
3
BA
45
-3
CMG
69
-3
EXR
59
4
DOW
30
2
IFF
53
2
LRCX
46
-2
EQR
60
6
T
48
3
PNR
74
5
PX
73
-6
SYY
47
-2
EQT
57
-3
CAH
60
2
Financhill
Back

Amicus Therapeutics Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
44

FOLD
Amicus Therapeutics

Last Price:
10.10
Seasonality Move:
8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Amicus Therapeutics Price Quote

$10.10
-0.28 (-2.7%)
(Updated: November 14, 2024 at 5:55 PM ET)

Amicus Therapeutics Key Stats

Sell
44
Amicus Therapeutics (FOLD) is a Sell
Day range:
$10.30 - $10.66
52-week range:
$9.02 - $14.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.44
P/B ratio:
17.53%
Volume:
2.6M
Avg. volume:
2.6M
1-year change:
1.07%
Market cap:
$3.1B
Revenue:
$399.4M
EPS:
$-0.34

How Much Does Amicus Therapeutics Make?

Is Amicus Therapeutics Growing As A Company?

  • What Is Amicus Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.37%
  • What Is Amicus Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Amicus Therapeutics Stock Price Performance

What Is Amicus Therapeutics 52-Week High & Low?

Amicus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Amicus Therapeutics?

Is Amicus Therapeutics Cash Flow Positive?

  • What Is FOLD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$26.5M
  • What Is Amicus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.2M
  • What Is Amicus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.1M

Amicus Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    FOLD return on invested capital is -19.5%
  • What Is Amicus Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -13.78%
  • What Is FOLD Return On Equity?
    ROE is a measure of profitability and is -71.17%

Amicus Therapeutics Earnings Date & Stock Price

Amicus Therapeutics Competitors

  • Who Are Amicus Therapeutics's Competitors?
    Below is a list of companies who compete with Amicus Therapeutics or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Ionis Pharmaceuticals Inc (IONS)
    • Krystal Biotech Inc (KRYS)
    • Tonix Pharmaceuticals Holding Corp (TNXP)

Amicus Therapeutics Dividend Yield

Amicus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 91.02%
Revenue: 36.73% 4.86%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 17.75
Upside from Last Price: 71%

Major Shareholders

  • How many FOLD shares are owned by institutional investors?
    495.8M FOLD shares are owned by institutional investors
  • How many FOLD shares are owned by insiders?
    5.5M FOLD shares are owned by insiders